Get the Stockscreener App
424.64
0.24%
1.01
Intuitive Surgical Inc stock is traded at $424.64, with a volume of 3.44M.
It is up +0.24% in the last 24 hours and down -6.43% over the past month.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
See More
Previous Close:
$423.63
Open:
$423.79
24h Volume:
3.44M
Relative Volume:
1.70
Market Cap:
$150.39B
Revenue:
$10.58B
Net Income/Loss:
$3.00B
P/E Ratio:
51.51
EPS:
8.2437
Net Cash Flow:
$2.83B
1W Performance:
-3.07%
1M Performance:
-6.43%
6M Performance:
-25.95%
1Y Performance:
-23.59%
1-Day Range:
$419.83
$426.81
1-Week Range:
$414.30
$442.94
52-Week Range:
$414.30
$603.88
Intuitive Surgical Inc Stock (ISRG) Company Profile
Name
Intuitive Surgical Inc
Sector
Industry
Phone
(408) 523-2100
Address
1020 KIFER ROAD, SUNNYVALE
Compare ISRG vs BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
424.64 | 150.03B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.12 | 40.89B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.29 | 32.02B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.56 | 31.12B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
190.57 | 29.51B | 5.54B | 1.52B | 1.74B | 10.37 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-11-26 | Upgrade | Citigroup | Neutral → Buy |
| Jan-27-26 | Initiated | TD Cowen | Buy |
| Dec-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Jul-23-25 | Downgrade | Erste Group | Buy → Hold |
| Jun-09-25 | Downgrade | Deutsche Bank | Hold → Sell |
| Jun-05-25 | Upgrade | Erste Group | Hold → Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-02-24 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jul-10-24 | Reiterated | Citigroup | Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Nov-17-23 | Initiated | HSBC Securities | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-19-23 | Reiterated | BTIG Research | Buy |
| Apr-19-23 | Reiterated | BofA Securities | Buy |
| Apr-19-23 | Reiterated | Citigroup | Buy |
| Apr-19-23 | Reiterated | Evercore ISI | In-line |
| Apr-19-23 | Reiterated | JP Morgan | Overweight |
| Apr-19-23 | Reiterated | Morgan Stanley | Equal-Weight |
| Apr-19-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-19-23 | Reiterated | Raymond James | Outperform |
| Apr-19-23 | Reiterated | Stifel | Buy |
| Apr-19-23 | Reiterated | Truist | Buy |
| Apr-19-23 | Reiterated | Wells Fargo | Overweight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-23-23 | Initiated | William Blair | Outperform |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-13-22 | Initiated | Mizuho | Neutral |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-25-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-25-22 | Downgrade | Redburn | Buy → Neutral |
| Jan-21-22 | Reiterated | BTIG Research | Buy |
| Jan-21-22 | Upgrade | Citigroup | Neutral → Buy |
| Jan-21-22 | Reiterated | Deutsche Bank | Hold |
| Jan-21-22 | Reiterated | Evercore ISI | In-line |
| Jan-21-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-21-22 | Reiterated | Piper Sandler | Neutral |
| Jan-21-22 | Reiterated | Raymond James | Outperform |
| Jan-21-22 | Reiterated | Robert W. Baird | Outperform |
| Jan-21-22 | Reiterated | Stifel | Buy |
| Jan-21-22 | Reiterated | UBS | Neutral |
| Jan-21-22 | Reiterated | Wells Fargo | Overweight |
| Jan-10-22 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Jul-21-21 | Reiterated | BofA Securities | Neutral |
| Jul-21-21 | Reiterated | Citigroup | Buy |
| Jul-21-21 | Reiterated | JP Morgan | Overweight |
| Jul-21-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Jul-21-21 | Reiterated | Piper Sandler | Neutral |
| Jul-21-21 | Reiterated | SVB Leerink | Mkt Perform |
| Jul-21-21 | Reiterated | Stifel | Buy |
| Jul-21-21 | Reiterated | UBS | Neutral |
| Jul-21-21 | Reiterated | Wells Fargo | Overweight |
| Jul-14-21 | Reiterated | Goldman | Buy |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Apr-21-21 | Upgrade | Oppenheimer | Underperform → Perform |
| Apr-21-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-01-21 | Initiated | Citigroup | Buy |
| Dec-15-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-28-20 | Initiated | Argus | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jul-20-20 | Reiterated | Bernstein | Outperform |
| Apr-28-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-17-20 | Downgrade | CFRA | Hold → Sell |
| Apr-17-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-09-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Apr-01-20 | Downgrade | Oppenheimer | Perform → Underperform |
| Jan-27-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-19 | Reiterated | Wells Fargo | Outperform |
| Nov-21-19 | Initiated | Oppenheimer | Perform |
| Jul-19-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-22-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-02-19 | Initiated | Deutsche Bank | Buy |
| Oct-31-18 | Reiterated | Piper Jaffray | Overweight |
| Oct-19-18 | Upgrade | Canaccord Genuity | Hold → Buy |
View All
Intuitive Surgical Inc Stock (ISRG) Latest News
The Bull Case For Intuitive Surgical (ISRG) Could Change Following A Key Commercial Leadership Shakeup - Yahoo Finance
Wall Street Thinks Intuitive Surgical Stock Can Soar Over 30%. Here's Why Analysts are Right. - AOL.com
Wall Street Thinks Intuitive Surgical Stock Can Soar Over 30%. Here's Why Analysts are Right. - The Motley Fool
Intuitive Surgical Names New Chief Commercial and Marketing Officer - The Globe and Mail
Why Intuitive Surgical, Inc. (ISRG) outpaced the stock market today - MSN
Wells Fargo Reaffirms Their Buy Rating on Intuitive Surgical (ISRG) - The Globe and Mail
Citi Keeps Their Buy Rating on Intuitive Surgical (ISRG) - The Globe and Mail
Intuitive Surgical, Inc. stock (US46120E6023): shares edge lower ahead of next valuation check - AD HOC NEWS
Intuitive Surgical (ISRG) Announces Key Leadership Changes - GuruFocus
Intuitive Surgical (ISRG) Welcomes New Chief Commercial and Mark - GuruFocus
Intuitive Surgical Inc stock (US4612021034): valuation metrics in focus after recent price weakness - AD HOC NEWS
Intuitive Surgical Inc. stock outperforms competitors on strong trading day - MarketWatch
Intuitive Surgical (NASDAQ: ISRG) promotes Taylor Patton to Chief Commercial and Marketing Officer - Stock Titan
Robotic-surgery Intuitive promotes Taylor Patton to commercial marketing chief - Stock Titan
Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton - GlobeNewswire
Intuitive Surgical, Inc. stock (US46120E6023): shares under pressure after recall-linked slide - AD HOC NEWS
Why is Intuitive Surgical (ISRG) down 7.2% since last earnings report? - MSN
Is Intuitive Surgical Inc (ISRG) a Bargain After 4.1% Drop? GF V - GuruFocus
Intuitive Surgical (ISRG) Is Pushing 100 Upgrades to Its da Vinci 5 Robot Starting June - Insider Monkey
Intuitive Surgical Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Here is why growth investors should buy Intuitive Surgical (ISRG) now - MSN
Intuitive Surgical, Inc. stock (US46120E6023): Robotic-surgery leader after latest earnings and grow - AD HOC NEWS
Here is Why Growth Investors Should Buy Intuitive Surgical (ISRG) Now - Yahoo Finance
Intuitive Surgical, Inc. stock (US46120E6023): Robotic surgery leader after latest quarterly results - AD HOC NEWS
Intuitive Surgical stock hits 52-week low at 417.52 USD By Investing.com - Investing.com India
Intuitive Surgical stock hits 52-week low at 417.52 USD - Investing.com
Intuitive Surgical Inc Stock (ISRG) Moved Down by 3.28% on May 27: Drivers Behind the Movement - TradingKey
Intuitive Surgical Recalls Put Da Vinci Reliability And Valuation In Focus - simplywall.st
Goldman Sachs Adjusts Price Target on Intuitive Surgical to $558 From $621, Maintains Buy Rating - Moomoo
ISRG vs. MDT: Which Surgical Robot Stock Is the Better Buy? - Yahoo Finance
Intuitive Surgical (ISRG) Announces Several Innovations to Advance Quintuple Aim - Insider Monkey
Is Intuitive Surgical (ISRG) One of the Best Robotic Surgery Stocks to Buy? - Insider Monkey
With EPS Growth And More, Intuitive Surgical (NASDAQ:ISRG) Makes An Interesting Case - Moomoo
Intuitive Surgical stock (US46120E6023): Robotic surgery leader digests post-earnings pullback - AD HOC NEWS
ISRG's Ion Platform: A Major Growth Engine in Lung Cancer Care? - Yahoo Finance
Intuitive Surgical, Inc. (ISRG) Stock Analysis: A 30.72% Upside Potential Beckons Healthcare Investors - DirectorsTalk Interviews
Intuitive Surgical, Inc. stock (US46120E6023): Q1 growth highlights da Vinci strength while shares c - AD HOC NEWS
Intuitive Surgical Fell 9% Over the Last 30 Days. Here’s Where the Stock Is Headed in 2026 - TIKR.com
A Look At Intuitive Surgical (ISRG) Valuation After Strong Q1 Beat And Raised Procedure Growth Outlook - simplywall.st
Intuitive surgical EVP Mark Brosius sells $15,945 in stock By Investing.com - Investing.com Nigeria
Intuitive Surgical, Inc. stock (US46120E6023): Da Vinci maker grows on strong procedure demand - AD HOC NEWS
Insider Sell Alert: Mark Brosius Sells Shares of Intuitive Surgi - GuruFocus
Intuitive surgical EVP Mark Brosius sells $15,945 in stock - Investing.com
Intuitive Surgical (ISRG) EVP Brosius sells 36 shares in planned trades - Stock Titan
Intuitive readies 100 updates and improvements for da Vinci 5 - MedTech Dive
Zacks Industry Outlook Highlights Electromed, Globus Medical and Intuitive Surgical - TradingView
Wells Fargo Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $654 - Moomoo
ISRG Stock Price, Quote & Chart | INTUITIVE SURGICAL INC (NASDAQ:ISRG) - ChartMill
3 Big Reasons ISRG Should Be On Your Watchlist - Yahoo Finance
Intuitive Surgical’s Da Vinci 5 Upgrades Aim To Deepen Moat For Investors - Yahoo Finance
Are Wall Street Analysts Bullish on Intuitive Surgical Stock? - Barchart.com
Intuitive Surgical Inc Stock (ISRG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.87%
0.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):